Relix® is
a range of Molecular diagnostic and Genetic
testing services offered by Reliance Life
Sciences for diagnosing several infectious
diseases and genetic disorders.
Qualitative Analysis
Tuberculosis (TB)
Hepatitis B
Hepatitis C
Human Papiloma Virus (HPV)
BK virus Qualitative
BCR / ABL Qualitative
Human Immunodeficiency Virus (HIV 1 & 2)
Cyto Megalo Virus (CMV)
Chikungunya
Chlamydia
Dengue
Epstein Barr Virus (EBV)
Enterovirus
Helicobacter Pylori
Hepatitis A
Herpes Simplex Virus (HSV 1 & 2)
Japanese Encephalitis Virus (JEV)
Malaria
Parvovirus B19
Rubella
Toxoplasma
Typhoid
Quantitative Analysis
HBV Quantitative Real-time
HCV Quantitative Real-time
HIV-1 Quantitative Real-time
BCR / ABL Quantitative Real-time
BK virus Quantitative Real-time
Cyto Megalo Virus (CMV) Real-time
Sequencing based tests
KRAS Mutation Analysis
EGFR Hotspot Mutations
HBV Genotyping
HCV Genotyping
HBV Drug Resistance test
Human Papilloma Virus (HPV)
HLA typing-A,B,DR
BCR/ABL Mutation Analysis
UGT1A1 Genotyping
Mitochondrial Mutations
Warfarin Dose Determination test
Cardio-Vascular Diseases (CVD) Risk Markers-
Factor V Leiden
MTHFR Mutation
Prothrombin Mutation
HLA B27
YMDD test
Cystic Fibrosis
Karyotyping
Karyotyping of Peripheral Blood Cells
Chromosomal breakage studies: Fanconi anaemia
Fragile X & Y Detection
Amniotic Fluid sample study
Cord Blood sample study
Chorionic Villi sample study
Karyotyping of Bone Marrow / Leukemic Blood
Fluorescence In-Situ
Hybridization (FISH)
HER-2/neu
Products of conception study
Pre-Implantation Genetic Diagnosis (PGD)
Angelman/Prader-Willi Syndrome
BCR / ABL translocation (9;22) in CML, AML, ALL
Chorionic Villi Sample study
Cord Blood sample study
PML/RARA
Peripheral Blood Cells study
Duplication SNRPN in Autism
Follicular Fluid FISH
Predictive Diagnostics
BRCA 1 & 2 Mutations study for familial Breast & Ovarian Cancer
RET gene Mutation study for familial Medullary Thyroid Carcinoma